DG
David L Grange
Chief Executive OfficerDirector

David L Grange insider trades: Pharmaceutical Product Development (PPDI) stock sales

Chief Executive Officer, Pharmaceutical Product Development Last trade Feb 28, 2011 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2005
2
Companies
last trade 2011

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 28, 2011PPDI↓ Sell$897K
Nov 3, 2010PPDI↓ Sell$1.3M
Aug 7, 2008PPDI↓ Sell$418K
Jul 26, 2007PPDI↓ Sell$184K
Feb 9, 2007PPDI↓ Sell$205K
May 24, 2006PPDI↓ Sell$362K
Nov 2, 2005PPDI↓ Sell$284K
Jul 26, 2005PPDI↓ Sell$172K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David L Grange's insider trades

David L Grange is Chief Executive Officer at Pharmaceutical Product Development (PPDI). Since Jul 26, 2005, David has reported no open-market purchases and 8 sales worth $3.9M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (21 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PPDI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.